Dr. Luis De Las Casas, MD
What this data tells you about Dr. De Las Casas
Dr. Luis De Las Casas is a cytopathology physician in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. De Las Casas performed 2,830 Medicare services across 1,802 unique beneficiaries.
Between the years covered by Open Payments, Dr. De Las Casas received a total of $8,400 from 2 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. De Las Casas is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity | 728 | $29 | $175 |
| Tissue staining for diagnosis, additional | 459 | $22 | $90 |
| Evaluation of fine needle aspirate with interpretation and report | 379 | $54 | $315 |
| Cell examination of specimen, selective cellular enhancement technique | 327 | $21 | $265 |
| Tissue staining for diagnosis, initial | 225 | $27 | $195 |
| Evaluation of fine needle aspirate | 213 | $27 | $184 |
| Special stained specimen slides to identify organisms including interpretation and report | 76 | $20 | $125 |
| Pathology cytologic examination of specimen during surgery, initial site | 50 | $48 | $242 |
| Microscopic genetic analysis of tumor, manual | 50 | $32 | $225 |
| Pathology examination of tissue using a microscope, moderately high complexity | 46 | $63 | $365 |
| Pathology cytologic examination of specimen during surgery, each additional site | 46 | $29 | $148 |
| Cell examination of specimen, concentration technique | 44 | $17 | $125 |
| Preparation of tissue for examination by removing any calcium present | 36 | $10 | $55 |
| Special stained specimen slides to examine tissue including interpretation and report | 36 | $9 | $74 |
| Pathology examination of tissue using a microscope, limited examination | 30 | $3 | $45 |
| Pathology examination of tissue using a microscope, moderately low complexity | 27 | $9 | $105 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 24 | $16 | $93 |
| Antibody evaluation, initial single antibody stain procedure | 21 | $27 | $195 |
| Pathology examination of tissue using a microscope, high complexity | 13 | $106 | $520 |
Industry Payment Transparency
Open Payments through 2022 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2022)
Associated products mentioned in payments ›
The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cytopathology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for cytopathology physician in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2022 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. De Las Casas is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), and high industry engagement (speaking/promotional, top 8%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. De Las Casas experienced with tissue pathology examination, moderate complexity?
Does Dr. De Las Casas receive payments from pharmaceutical companies?
How do Dr. De Las Casas's costs compare to other cytopathology physicians in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology